[go: up one dir, main page]

DK1214061T3 - Anvendelse af docetaxel til behandling af hepatocellulært carcinom - Google Patents

Anvendelse af docetaxel til behandling af hepatocellulært carcinom

Info

Publication number
DK1214061T3
DK1214061T3 DK00964144T DK00964144T DK1214061T3 DK 1214061 T3 DK1214061 T3 DK 1214061T3 DK 00964144 T DK00964144 T DK 00964144T DK 00964144 T DK00964144 T DK 00964144T DK 1214061 T3 DK1214061 T3 DK 1214061T3
Authority
DK
Denmark
Prior art keywords
docetaxel
hepatocellular carcinoma
treatment
mum
paclitaxel
Prior art date
Application number
DK00964144T
Other languages
English (en)
Inventor
Chin-Wen Chi
Heng-Liang Lin
Tsung-Yun Liu
Wing-Yiu Lui
Gar-Yang Chau
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of DK1214061T3 publication Critical patent/DK1214061T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
DK00964144T 1999-08-31 2000-08-29 Anvendelse af docetaxel til behandling af hepatocellulært carcinom DK1214061T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9920548.6A GB9920548D0 (en) 1999-08-31 1999-08-31 Treatment of hepatocellular carcinoma
PCT/EP2000/008782 WO2001015675A2 (en) 1999-08-31 2000-08-29 Use of docetaxel for treating hepatocellular carcinoma

Publications (1)

Publication Number Publication Date
DK1214061T3 true DK1214061T3 (da) 2004-11-01

Family

ID=10860081

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00964144T DK1214061T3 (da) 1999-08-31 2000-08-29 Anvendelse af docetaxel til behandling af hepatocellulært carcinom

Country Status (34)

Country Link
US (2) US20030158249A1 (da)
EP (1) EP1214061B1 (da)
JP (1) JP4866522B2 (da)
KR (1) KR100670416B1 (da)
CN (1) CN1174748C (da)
AT (1) ATE269700T1 (da)
AU (1) AU777583B2 (da)
BG (1) BG65913B1 (da)
BR (1) BR0013625A (da)
CA (1) CA2382294C (da)
CZ (1) CZ301378B6 (da)
DE (1) DE60011794T2 (da)
DK (1) DK1214061T3 (da)
EA (1) EA004804B1 (da)
EE (1) EE05124B1 (da)
ES (1) ES2218223T3 (da)
GB (1) GB9920548D0 (da)
HK (1) HK1048944B (da)
HR (1) HRP20020171A2 (da)
HU (1) HU228861B1 (da)
IL (2) IL147489A0 (da)
ME (1) MEP7809A (da)
MX (1) MXPA02002041A (da)
NO (1) NO328527B1 (da)
NZ (1) NZ517604A (da)
PL (1) PL212612B1 (da)
PT (1) PT1214061E (da)
RS (1) RS50148B (da)
SI (1) SI1214061T1 (da)
SK (1) SK286378B6 (da)
TW (1) TW589180B (da)
UA (1) UA72927C2 (da)
WO (1) WO2001015675A2 (da)
ZA (1) ZA200201408B (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1268619C (zh) * 2003-05-08 2006-08-09 上海迪赛诺化学制药有限公司 多烯紫杉醇三水化合物的制备方法
PT1694660E (pt) * 2003-12-12 2009-07-16 Quiral Quimica Do Brasil Processo de preparação de ingredientes farmacêuticos activos (api) anidros e hidratados; composições farmacêuticas estáveis preparadas a partir dos mesmos e utilizações das referidas composições
US7449196B2 (en) * 2004-07-09 2008-11-11 Robert Sabin Anti tumor compositions and methods of use
BRPI0615265A8 (pt) 2005-08-31 2018-03-06 Abraxis Bioscience Llc composições compreendendo agentes farmacêuticos pouco hidrossoluíveis e agentes antimicrobianos
JP5368093B2 (ja) * 2005-08-31 2013-12-18 アブラクシス バイオサイエンス， エルエルシー 増大した安定性を有する難水溶性薬剤の組成物および調製の方法
US9839667B2 (en) 2005-10-14 2017-12-12 Allergan, Inc. Prevention and treatment of ocular side effects with a cyclosporin
US20080081051A1 (en) * 2006-09-28 2008-04-03 Robert Sabin Method of manufacturing anti-tumor and anti-viral compositions
CA2683712A1 (en) * 2007-04-20 2009-01-15 Sun Pharmaceutical Industries Limited Pharmaceutical compositions
FR2917088B1 (fr) * 2007-06-08 2009-09-04 Aventis Pharma Sa Dissolution directe du docetaxel dans un solvant dans le polysorbate 80
US8541360B2 (en) * 2008-11-19 2013-09-24 Ben Venue Laboratories, Inc. Parenteral formulations comprising sugar-based esters and ethers
ES2580135T3 (es) 2010-03-26 2016-08-19 Abraxis Bioscience, Llc Métodos de tratamiento de carcinoma hepatocelular
SG185389A1 (en) * 2010-05-03 2012-12-28 Teikoku Pharma Usa Inc Non-aqueous taxane pro-emulsion formulations and methods of making and using the same
US8842114B1 (en) 2011-04-29 2014-09-23 Nvidia Corporation System, method, and computer program product for adjusting a depth of displayed objects within a region of a display
JO3685B1 (ar) 2012-10-01 2020-08-27 Teikoku Pharma Usa Inc صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها
US20160250177A1 (en) * 2015-02-17 2016-09-01 Mallinckrodt Llc Modified docetaxel liposome formulations and uses thereof

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601675B1 (fr) * 1986-07-17 1988-09-23 Rhone Poulenc Sante Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2629819B1 (fr) * 1988-04-06 1990-11-16 Rhone Poulenc Sante Procede de preparation de derives de la baccatine iii et de la desacetyl-10 baccatine iii
US5543154A (en) * 1991-12-27 1996-08-06 Merck & Co., Inc. Controlled release nifedipine delivery device
DE69324504T2 (de) * 1993-01-19 1999-08-26 Warner-Lambert Co. Stabilisierte, oral anzuwendende zusammensetzung enthaltend die verbindung ci-981 und verfahren
US5801029A (en) * 1993-02-16 1998-09-01 Onyx Pharmaceuticals, Inc. Cytopathic viruses for therapy and prophylaxis of neoplasia
US5436243A (en) * 1993-11-17 1995-07-25 Research Triangle Institute Duke University Aminoanthraquinone derivatives to combat multidrug resistance
FR2718963B1 (fr) * 1994-04-25 1996-05-24 Rhone Poulenc Rorer Sa Nouvelle composition pharmaceutique à base de taxoïdes.
FR2722191B1 (fr) * 1994-07-08 1996-08-23 Rhone Poulenc Rorer Sa Procede de preparation du trihydrate du (2r,3s)-3-tertbutoxycarbonylamino-2-hydroxy-3-phenylpropionate de 4-acetoxy2alpha-benzoyloxy-5beta,20epoxy-1,7beta,10beta trihydroxy-9-oxo-tax-11-en-13alpha-yle
US5968972A (en) 1995-10-26 1999-10-19 Baker Norton Pharmaceuticals, Inc. Method for increasing the oral bioactivity of pharmaceutical agents
US6245805B1 (en) * 1995-10-26 2001-06-12 Baker Norton Pharmaceuticals, Inc. Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
FR2742751B1 (fr) * 1995-12-22 1998-01-30 Rhone Poulenc Rorer Sa Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
US6503893B2 (en) * 1996-12-30 2003-01-07 Bone Care International, Inc. Method of treating hyperproliferative diseases using active vitamin D analogues
US6471943B1 (en) * 1996-12-30 2002-10-29 Battelle Pulmonary Therapeutics, Inc. Formulation and method for treating neoplasms by inhalation
KR100789008B1 (ko) * 1997-06-27 2007-12-26 아브락시스 바이오사이언스 인크. 신규 약물 제제
JP3775780B2 (ja) * 1997-09-18 2006-05-17 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 薬剤の経口的バイオアベイラビリテイを向上させるための縮合イミダゾール誘導体
KR20010031501A (ko) * 1997-10-31 2001-04-16 추후제출 5-알파 환원효소 활성을 조절하는 방법 및 조성물
UA73092C2 (uk) * 1998-07-17 2005-06-15 Брістол-Майерс Сквібб Компані Таблетка з ентеросолюбільним покриттям і спосіб її приготування
KR20010109275A (ko) * 1998-12-23 2001-12-08 로저 에이. 윌리암스 종양치료의 병용치료로서 사이클로옥시게나제-2 억제제와기질 금속단백분해효소 억제제를 사용하는 방법
GB9909925D0 (en) * 1999-04-29 1999-06-30 Pharmacia & Upjohn Spa Combined preparations comprising anthracycline derivatives
MX2007014329A (es) * 2005-12-13 2008-03-19 Teva Pharma Forma cristalina de hemi-calcio de atorvastatina y procesos para la preparacion de ella.

Also Published As

Publication number Publication date
PL212612B1 (pl) 2012-10-31
EP1214061B1 (en) 2004-06-23
HK1048944A1 (en) 2003-04-25
SK286378B6 (sk) 2008-08-05
KR20020060166A (ko) 2002-07-16
NO20020829L (no) 2002-02-20
EP1214061A2 (en) 2002-06-19
CA2382294C (en) 2008-06-03
PL353198A1 (en) 2003-11-03
BG106460A (bg) 2002-09-30
ME00624B (me) 2011-12-20
CN1174748C (zh) 2004-11-10
ES2218223T3 (es) 2004-11-16
NO20020829D0 (no) 2002-02-20
MEP7809A (en) 2011-12-20
ZA200201408B (en) 2003-07-30
WO2001015675A3 (en) 2001-09-20
NZ517604A (en) 2004-04-30
SI1214061T1 (en) 2004-12-31
HRP20020171A2 (en) 2004-02-29
CA2382294A1 (en) 2001-03-08
DE60011794D1 (de) 2004-07-29
HU228861B1 (hu) 2013-06-28
JP4866522B2 (ja) 2012-02-01
EE05124B1 (et) 2009-02-16
RS50148B (sr) 2009-05-06
SK2712002A3 (en) 2002-07-02
IL147489A (en) 2006-06-11
HUP0203197A2 (hu) 2003-01-28
BR0013625A (pt) 2002-05-14
US20080045584A1 (en) 2008-02-21
US20030158249A1 (en) 2003-08-21
IL147489A0 (en) 2002-08-14
CZ2002739A3 (cs) 2002-06-12
UA72927C2 (uk) 2005-05-16
HUP0203197A3 (en) 2005-01-28
KR100670416B1 (ko) 2007-01-17
GB9920548D0 (en) 1999-11-03
YU11402A (sh) 2005-07-19
JP2003508427A (ja) 2003-03-04
AU777583B2 (en) 2004-10-21
TW589180B (en) 2004-06-01
HK1048944B (zh) 2005-04-22
NO328527B1 (no) 2010-03-08
EE200200087A (et) 2003-04-15
ATE269700T1 (de) 2004-07-15
AU7516800A (en) 2001-03-26
MXPA02002041A (es) 2002-08-20
WO2001015675A2 (en) 2001-03-08
CZ301378B6 (cs) 2010-02-03
DE60011794T2 (de) 2005-07-14
PT1214061E (pt) 2004-09-30
EA200200313A1 (ru) 2002-08-29
CN1372466A (zh) 2002-10-02
EA004804B1 (ru) 2004-08-26
BG65913B1 (bg) 2010-05-31

Similar Documents

Publication Publication Date Title
DK1214061T3 (da) Anvendelse af docetaxel til behandling af hepatocellulært carcinom
DK1411938T3 (da) Anvendelse af cyclopamin til fremstilling af et medikament til behandling af psoriasis
NO20034204D0 (no) Farmasöytiske kombinasjoner til behandling av kreft
BR0312573A (pt) Derivados de fenil-[4-(3-fenil-1h-pirazol-4-il)-pirimidin-2-il]-amina
DE60143393D1 (de) Modifizierte formen pharmazeutisch aktiver agenzien und verwendungen dafür
DK1349856T3 (da) Isoindolin-1-on-glucokinase-aktivatorer
ATE408601T1 (de) Fredericamycin-derivate
ATE478662T1 (de) Arzneilösungen enthaltend modafinilverbindungen
DK1305037T3 (da) Smertestillende medikament
DK1150704T3 (da) Melagatran til behandling af betændelse
ATE411036T1 (de) Verwendung von aplidine in der behandlung von pankreaskrebs
NO20032597D0 (no) Anvendelse av SARP-1 for behandlingen og/eller forebyggingen av skleroderma
TR200302134T4 (tr) 2-metil-tiazolidin-2,4-dikarboksilik asit ve/veya bunun fizyolojik olarak uygun tuzlarının anti-kanser ajanları olarak kullanımı.
DK1603584T3 (da) Aplidine til behandling af multipelt myelom
WO2002024181A3 (en) The use of melatonin for induction of general anesthesia
SE0203817D0 (sv) New composition
DK1150682T3 (da) Ubichinon Qn til behandling af migrænesmerter
ATE306940T1 (de) Zusammensetzung gegen coccidiose
ITTO20001109A0 (it) Composizione farmaceutica per il trattamento anti m. ulcerans.
DK1355650T3 (da) Kombination af aktive bestanddele, som indeholder alfuzosin og apomorphin